Paolo Tombesi Net Worth & Insider Trades

Paolo Tombesi - Chief Financial Officer, Epizyme, Inc

As of February 5, 2021

What is Paolo Tombesi's Net Worth?

The current estimated net worth of Epizyme, Inc's Chief Financial Officer, Paolo Tombesi, is estimated to be about $1.38M . Paolo Tombesi owns about 53,465 units of Epizyme, Inc common stock. In the last 2 years at Epizyme, Inc, Paolo Tombesi has sold an estimated value of $131.2K worth.

What is Paolo Tombesi's Past Insider Trading?

Paolo Tombesi's largest sale order was 1,805 units , worth over $29.15K on June 30, 2020. In total, Paolo Tombesi has made about 8 transactions over 2 years of their time at Epizyme, Inc. Paolo Tombesi usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 1,021 units , worth over $11.45K on February 5, 2021.

PAOLO TOMBESI

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Paolo Tombesi's Salary in 2020?

As Chief Financial Officer of Epizyme, Inc, Paolo Tombesi has a total base salary of $460,000 . Paolo Tombesi received compensation valued at about $1,683,734 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of restricted stock awards of $250,006 , option awards of $750,730 , other earnings, plans or compensations of $174,800 , and other compensation of $48,198 .

What is Paolo Tombesi's' Mailing Address?

  • Mailing address is 10 Finderne Avenue Building 10 Bridgewater NJ 08807 NJ

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

What are Epizyme, Inc's Past Insider Trades?

Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $156.28M and bought an estimated value of $381.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director,  Robert Copeland, President Research and CSO,  and Andrew Singer, EVP & CFO .

Epizyme, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...